All PlansAdministrativeMedium impact
Antidepressant Medication Management (AMM)
Blue Cross Blue Shield of Rhode Island·RI · Family Medicine, Internal Medicine, Psychiatry +1 more·Behavioral Health
Effective date
Mar 1, 2020
We identified it
Jun 19, 2026
Summary
This policy outlines HEDIS measure requirements for Antidepressant Medication Management (AMM), tracking patients 18+ with major depression who remain on antidepressant treatment for at least 84 days (acute phase) and 180 days (continuation phase). Follow-up visits should occur within 6 weeks maximum to optimize medication adherence.
Action Required
Providers must schedule follow-up visits within 6 weeks for patients on antidepressant medication with major depression diagnosis. Update EMR templates to include medication adherence tracking and patient education reminders about continuing treatment for at least 6 months. Billing team should flag AMM-eligible patients for proper visit scheduling to meet HEDIS quality measures.